These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29268695)

  • 1. An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.
    Thillaiyampalam G; Liberante F; Murray L; Cardwell C; Mills K; Zhang SD
    BMC Bioinformatics; 2017 Dec; 18(1):581. PubMed ID: 29268695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
    Wen Q; Kim CS; Hamilton PW; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies.
    Wen Q; O'Reilly P; Dunne PD; Lawler M; Van Schaeybroeck S; Salto-Tellez M; Hamilton P; Zhang SD
    BMC Syst Biol; 2015; 9 Suppl 5(Suppl 5):S4. PubMed ID: 26356760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining gene signatures improves prediction of breast cancer survival.
    Zhao X; Rødland EA; Sørlie T; Naume B; Langerød A; Frigessi A; Kristensen VN; Børresen-Dale AL; Lingjærde OC
    PLoS One; 2011 Mar; 6(3):e17845. PubMed ID: 21423775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
    Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
    Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning based on gene expression data for human HER2-positive breast cancer.
    Khanjani F; Jafari L; Azadiyan S; Roozbehi S; Moradian C; Zahiri J; Hasannia S; Sajedi RH
    Arch Biochem Biophys; 2021 Nov; 712():109043. PubMed ID: 34597657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
    Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
    Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.
    McArt DG; Zhang SD
    PLoS One; 2011 Jan; 6(1):e16382. PubMed ID: 21305029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures.
    Chen J; Sam L; Huang Y; Lee Y; Li J; Liu Y; Xing HR; Lussier YA
    J Biomed Inform; 2010 Jun; 43(3):385-96. PubMed ID: 20350617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing Cancer - Functional Gene Set - Compound Networks to Identify Putative Drugs for Breast Cancer.
    Hsiao TH; Chiu YC; Chen YH; Hsu YC; Chen HH; Chuang EY; Chen Y
    Comb Chem High Throughput Screen; 2018; 21(2):74-83. PubMed ID: 29303076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy.
    Hallett RM; Pond G; Hassell JA
    BMC Med Genomics; 2012 May; 5():16. PubMed ID: 22578285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A resampling-based meta-analysis for detection of differential gene expression in breast cancer.
    Gur-Dedeoglu B; Konu O; Kir S; Ozturk AR; Bozkurt B; Ergul G; Yulug IG
    BMC Cancer; 2008 Dec; 8():396. PubMed ID: 19116033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
    West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD
    Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357
    [No Abstract]   [Full Text] [Related]  

  • 15. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
    Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
    Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-specific micro-RNA expression signatures in breast cancer progression.
    Haakensen VD; Nygaard V; Greger L; Aure MR; Fromm B; Bukholm IR; Lüders T; Chin SF; Git A; Caldas C; Kristensen VN; Brazma A; Børresen-Dale AL; Hovig E; Helland Å
    Int J Cancer; 2016 Sep; 139(5):1117-28. PubMed ID: 27082076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data.
    McArt DG; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Hamilton PW; Zhang SD
    PLoS One; 2013; 8(6):e66902. PubMed ID: 23840550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification association of drug-disease by using functional gene module for breast cancer.
    Zhu L; Zhu F
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S3. PubMed ID: 26045063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?
    Merdad A; Karim S; Schulten HJ; Jayapal M; Dallol A; Buhmeida A; Al-Thubaity F; GariI MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S11. PubMed ID: 25923423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
    Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.